Suppressors of cytokine signaling regulate angiotensin II-activated Janus kinase-signal transducers and activators of transcription pathway in renal cells

Journal of the American Society of Nephrology

Volumn 16, Issue 6, 2005, Pages 1673-1683

  Hernández Vargas, Purificación ^a   López Franco, Oscar ^a   Sanjuán, Guillermo ^a   Rupérez, Mónica ^a   Ortiz Muñoz, Guadalupe ^a   Suzuki, Yusuke ^b   Aguado Roncero, Pablo ^a   Pérez Tejerizo, Gloria ^a   Blanco, Julia ^c   Egido, Jesús ^a   Ruiz Ortega, Marta ^a   Gómez Guerrero, Carmen ^a,d  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b JUNTENDO UNIVERSITY   (Japan)

^c HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^d Hospital UniversitarioFundación Jiménez Díaz   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; JANUS KINASE; PROTEIN C FOS; PROTEIN C JUN; STAT1 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 1; SUPPRESSOR OF CYTOKINE SIGNALING 3; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR ANTAGONIST; CYTOKINE; DNA BINDING PROTEIN; JAK2 PROTEIN, HUMAN; JAK2 PROTEIN, MOUSE; JAK2 PROTEIN, RAT; JANUS KINASE 2; LOSARTAN; ONCOPROTEIN; PROTEIN TYROSINE KINASE; REPRESSOR PROTEIN; SIGNAL PEPTIDE; STAT1 PROTEIN, HUMAN; STAT1 PROTEIN, MOUSE; STAT1 PROTEIN, RAT; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; KIDNEY CELL; KIDNEY DISEASE; KIDNEY TUBULE CELL; MESANGIUM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RAT; SIGNAL TRANSDUCTION; ANIMAL; CELL CULTURE; DRUG ANTAGONISM; DRUG EFFECT; EPITHELIUM CELL; KIDNEY; METABOLISM; PHYSIOLOGY; TRANSACTIVATION;

ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; CELLS, CULTURED; CYTOKINES; DNA-BINDING PROTEINS; EPITHELIAL CELLS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; JANUS KINASE 2; KIDNEY; LOSARTAN; MICE; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; RATS; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

EID: 26944452881     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2004050374     Document Type: Article

References (47)

1. Darnell JE: STATs and gene regulation. Science 277: 1630-1635, 1997
2. Shuai K, Liu B: Regulation of the JAK-STAT signalling in the immune system. Nat Rev Immunol 3: 900-911, 2003
3. Starr R, Wilson TA, Viney EM, Murray LJL, Rayner JR, Jenkins BJ, Gonda TJ, Alexander WS, Metcalf D, Nicola NA, Hilton DJ: A family of cytokine-inducible inhibitors of signalling. Nature 387: 917-921, 1997
4. Hilton DJ, Richardson RT, Alexander WS, Viney EM, Wilson TA, Sprigg NS, Starr R, Nicholson SE, Metcalf D, Nicola NA: Twenty proteins containing a C-terminal SOCS box from five structural classes. Proc Natl Acad Sci U S A 95: 114-119, 1998
5. Kubo M, Hasana T, Yoshimura A: Suppressors of cytokine signaling and immunity. Nat Immunol 4: 1169-1176, 2003
6. Soriano SF, Hernanz-Falcon P, Rodriguez-Frade JM, Martin de Ana A, Garzon R, Carvalho-Pinto C, Vila-Coro AJ, Zaballos A, Balomenos D, Martinez-A C, Mellado M: Functional inactivation of CXC chemokine receptor 4-mediated responses through SOCS3 up-regulation. J Exp Med 196: 311-321, 2002
7. Kim S, Iwao H: Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol Rev 52: 11-34, 2000
8. Ruiz-Ortega M, Lorenzo O, Suzuki Y, Rupérez M, Egido J: Proinflammatory actions of angiotensins. Curr Opin Nephrol Hypertens 10: 321-329, 2001
9. Guo DF, Sun YL, Hamet P, Inagami T: The angiotensin II type 1 receptor and receptor-associated proteins. Cell Res 11: 165-180, 2001
10. Touyz RM, Berry C: Recent advances in angiotensin II signalling. Braz J Med Biol Res 35: 1001-1015, 2002
11. Suzuki Y, Ruiz-Ortega M, Lorenzo O, Rupérez M, Esteban V, Egido J: Inflammation and angiotensin II. Int J Biochem Cell Biol 35: 881-900, 2003
12. Ruiz-Ortega M, Lorenzo O, Rupérez M, Blanco J, Egido J: Systemic infusion of angiotensin II into normal rats activates nuclear factor-kappaB and AP-1 in the kidney: Role of AT1 and AT2 receptors. Am J Pathol 158: 1743-1756, 2001
13. Wolf G, Wenzel U, Burns KD, Harris RC, Stahl RA, Thaiss F: Angiotensin II activates nuclear transcription factor-kappaB through AT1 and AT2 receptors. Kidney Int 61: 1986-1995, 2002
14. Suzuki Y, Gomez-Guerrero C, Shirato I, Lopez-Franco O, Hernandez-Vargas P, Sanjuan G, Ruiz-Ortega M, Sugaya T, Okumura K, Tomino Y, Ra C, Egido J: Susceptibility to T cell-mediated injury in immune complex disease is linked to local activation of renin-angiotensin system: The role of NF-AT pathway. J Immunol 169: 4136-4146, 2002
15. Marrero MB, Schieffer B, Paxton WG, Heerdt L, Berk BC, Delafontaine P, Bernstein KE: Direct stimulation of Jak/Stat pathway by the angiotensin II AT1 receptor. Nature 375: 247-250, 1995
16. Ali MS, Sayeski PP, Bernstein KE: Jak2 acts as both a STAT1 kinase and as a molecular bridge linking STAT1 to the angiotensin II AT1 receptor. J Biol Chem 275: 15586-15593, 2000
17. Bernstein KE, Sayeski PP, Doan T, Farmer PK, Showkat-Ali M: Signal transduction pathways of angiotensin II in the kidney. Contrib Nephrol 135: 16-33, 2001
18. Sakatsume M, Narita I, Yamazaki H, Saito A, Nakagawa Y, Kuriyama H, Kuwano R, Gejyo F, Arakawa M: Down-regulation of interferon-gamma signaling by gene transfer of Stat1 mutant in mesangial cells. Kidney Int 57: 455-463, 2000
19. Nakashima O, Terada Y, Hanada S, Yamamoto K, Kuwahara M, Sasaki S, Marumo F: Activated STAT1 suppresses proliferation of cultured rat mesangial cells. Kidney Int 57: 2249-2257, 2000
20. Seebach FA, Welte T, Fu XY, Block LH, Kashgarian M: Differential activation of the STAT1 pathway by angiotensin II via angiotensin type 1 and type 2 receptors in cultured human fetal mesangial cells. Exp Mol Pathol 70: 265-273, 2001
21. Amiri F, Shaw S, Wang X, Tang J, Waller JL, Eaton DC, Marrero MB: Angiotensin II activation of the JAK/STAT pathway in mesangial cells is altered by high glucose. Kidney Int 61: 1605-1616, 2002
22. Maruyama H, Huguchi N, Nishikawa Y, Hirahara H, Iino N, Kameda S, Kawachi H, Yaoita E, Gejyo F, Miyazaki J: Kidney-targeted naked DNA transfer by retrograde renal vein injection in rats. Hum Gen Ther 13: 455-468, 2002
23. Gómez-Guerrero C, Duque N, Egido J: Stimulation of Fc(alpha) receptors induces tyrosine phosphorylation of phospholipase C-gamma(1), phosphatidylinositol phosphate hydrolysis, and Ca2+ mobilization in rat and human mesangial cells. J Immunol 156: 4369-4376, 1996
24. Hisada Y, Sugaya T, Yamagouchi M, Uchida H, Fujimura H, Sakurai H, Fukamizu A, Murakami K: Angiotensin II plays a pathogenic role in immune-mediated renal injury in mice. J Clin Invest 103: 627-635, 1999
25. Leonard MO, Hannan K, Burne MJ, Lappin DWP, Doran P, Coleman P, Stenson C, Taylor CT, Daniels F, Godson C, Petasis NA, Rabb H, Brady HR: 15-epo-16 (para-fluorophenoxy)-lipoxin A4-metyl ester, a synthetic analogue of 15-epi-lipoxin A4, is protective in experimental ischemic acute renal failure. J Am Soc Nephrol 13: 1657-1662, 2002
26. Gómez-Guerrero C, López-Franco O, Sanjuán G, Hernández-Vargas P, Suzuki Y, Ortiz-Muñoz G, Blanco J, Egido J: Suppressors of cytokine signaling (SOCS) regulate Fc receptor signaling and cell activation during immune renal injury. J Immunol 172: 6969-6977, 2004
27. Ruiz-Ortega M, Ruperez M, Lorenzo O, Esteban V, Blanco J, Mezzano S, Egido J: Angiotensin II regulates the synthesis of proinflammatory cytokines and chemokines in the kidney. Kidney Int 82: 12-22, 2002
28. Burson JM, Aguilera G, Gross KW, Sigmund CD: Differential expression of angiotensin receptor 1A and 1B in mouse. Am J Physiol 267: E260-E267, 1994
29. Omiya T, Yamauchi T, Ogura T, Asanuma M, Ota Z: Angiotensin II induces in vivo c-fos expression from rat renal cortex and medulla. Ren Physiol Biochem 18: 81-88, 1995
30. Wolf G, Neilson EG: Angiotensin II induces cellular hypertrophy in cultured murine proximal tubular cells. Am J Physiol 259: F768-F77, 1990
31. Marrero MB, Venema VJ, Ju H, Eaton DC, Venema RC: Regulation of angiotensin II-induced JAK2 tyrosine phosphorylation: Roles of SHP-1 and SHP-2. Am J Physiol 275: C1216-C1223, 1998
32. Doan T, Farmer P, Cooney T, Ali MS: Selective downregulation of angiotensin II receptor type 1A signalling by protein tyrosine phosphatase SHP-2 in vascular smooth muscle cells. Cell Signal 16: 301-311, 2004
33. Sasser JM, Pollock JS, Pollock DM: Renal endothelin in chronic angiotensin II hypertension. Am J Physiol Regul Integr Comp Physiol 283: R243-R248, 2002
34. Border WA, Noble NA: Interactions of transforming growth factor-beta and angiotensin II in renal fibrosis. Hypertension 31: 181-188, 1998
35. Rupérez M, Ruiz-Ortega M, Esteban V, Lorenzo O, Mezzano S, Plaza JJ, Egido J: Angiotensin II increases connective tissue growth factor in the kidney. Am J Pathol 163: 1937-1947, 2003
36. Hamaguchi A, Kim S, Yano M, Yamanaka S, Iwao H: Activation of glomerular mitogen-activated protein kinases in angiotensin II-mediated hypertension. J Am Soc Nephrol 9: 372-380, 1998
37. Calegari VC, Bezerra RM, Torsoni MA, Torsoni AS, Franchini KG, Saad MJ, Velloso LA: Suppressor of cytokine signaling 3 is induced by angiotensin II in heart and isolated cardiomyocytes, and participates in desensitization. Endocrinology 144: 4586-4596, 2003
38. Diamond P, Doran P, Brady HR, McGinty A: Suppressors of cytokine signalling (SOCS): Putative modulators of cytokine bioactivity in health and disease. J Nephrol 13: 9-14, 2000
39. Horiuchi M, Hayashida W, Akishita M, Tamura K, Daviet L, Lehtonen JY, Dzau VJ: Stimulation of different subtypes of angiotensin II receptors, AT1 and AT2 receptors, regulates STAT activation in negative crosstalk. Circ Res 84: 876-882, 1999
40. Bartoe JL, Nathanson NM: Independent roles of SOCS-3 and SHP-2 in the regulation of neuronal gene expression by leukemia inhibitory factor. Mol Brain Res 107: 108-119, 2002
41. Banerjee A, Banks AS, Nawijin MC, Chen XP, Rothman PB: Suppressor of cytokine signaling 3 inhibits activation of NFATp. J Immunol 168: 4277-4281, 2002
42. Cacalano NA, Sanden D, Johnston JA: Tyrosine-phosphorylated SOCS-3 inhibits STAT activation but binds to p120 RasGAP and activates Ras. Nat Cell Biol 3: 460-465, 2001
43. Park SH, Kim KE, Hwang HY, Kim TY: Regulatory effect of SOCS on NF-kappaB activity in murine monocytes/macrophages DNA. Cel Biol 22: 131-139, 2003
44. Yasukawa H, Hoshijima M, Gu Y, Nakamura T, Pradervand S, Hanada T, Hanakawa Y, Yoshimura A, Ross J Jr, Chien KR: Suppressor of cytokine signaling-3 is a biomechanical stress-inducible gene that suppresses gp130-mediated cardiac myocyte hypertrophy and survival pathways. J Clin Invest 108: 1459-1467, 2001
45. Shouda T, Yoshida T, Hanada T, Wakioka T, Oishi M, Miyoshi K, Setsuro K, Kosai K, Hanakawa Y, Hashimoto K, Nagata K, Yoshimura A: Induction of the cytokine signal regulator SOCS3/CIS3 as a therapeutic strategy for treating inflammatory arthritis. J Clin Invest 108: 1781-1788, 2001
46. Egan PJ, Lawlor KE, Alexander WS, Wicks IP: Suppressor of cytokine signaling-1 regulates acute inflammatory arthritis and T cell activation. J Clin Invest 111: 915-924, 2003
47. Rao VLR, Bowen KK, Dhodda VK, Song G, Franklin JL, Gavva NR, Dempsey RJ: Gene expression analysis of spontaneously hypertensive rat cerebral cortex following transient focal cerebral ischemia. J Neurochem 83: 1072-1086, 2002